Phenanthraquinone inhibits eNOS activity and suppresses vasorelaxation
Department of Environmental Medicine, Institute of Community Medicine, Master's Program in Environmental Sciences, Graduate School Doctoral Program in Medical Sciences, Cardiovascular Division, Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibar...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 2001-07, Vol.281 (1), p.25-R30 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Department of Environmental Medicine, Institute of Community
Medicine, Master's Program in Environmental Sciences, Graduate
School Doctoral Program in Medical Sciences, Cardiovascular
Division, Department of Internal Medicine, Institute of Clinical
Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575; and
Department of Geriatrics, Nagoya University School of Medicine,
Showa-ku, Nagoya 466, Japan
Diesel exhaust particles cause an impairment of
endothelium-dependent vasorelaxation and are associated with
cardiopulmonary-related diseases and mortality, but the mechanistic
details are poorly understood. Since we reported previously that
phenanthraquinone, an environmental chemical contained in diesel
exhaust particles, suppresses neuronal nitric oxide synthase (nNOS)
activity by shunting electrons away from the normal catalytic pathway,
it was hypothesized that phenanthraquinone inhibits endothelial NOS
(eNOS) activity and affects vascular tone. Therefore, the effects of
phenanthraquinone on eNOS activity, endothelium-dependent relaxation,
and blood pressure were examined in the present study.
Phenanthraquinone inhibited NO formation evaluated by citrulline formed
by total membrane fraction of bovine aortic endothelial cells with an
IC 50 value of 0.6 µM. A kinetic study revealed that
phenanthraquinone is a competitive inhibitor with respect to NADPH
and a noncompetitive inhibitor with respect to L -arginine.
Endothelium-dependent relaxation of rat aortic rings by ACh was
significantly inhibited by phenanthraquinone (5 µM), whereas the
endothelium-independent relaxation by nitroglycerin was not.
Furthermore, an intraperitoneal injection of phenanthraquinone (0.36 mmol/kg) to rats resulted in an elevation of blood pressure (1.4-fold,
P |
---|---|
ISSN: | 0363-6119 1522-1490 |
DOI: | 10.1152/ajpregu.2001.281.1.r25 |